Opendata, web and dolomites

kINPen

Developing a high-innovative portable cold plasma device for efficient healing of chronic wounds in veterinary medicine

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 kINPen project word cloud

Explore the words cloud of the kINPen project. It provides you a very rough idea of what is the project "kINPen" about.

months    ions    infection    resistance    successfully    vet    farm    investment    radicals    antibiotic    health    urgently    100    approximate    radiation    treatment    multidrug    sales    wounds    time    technologies    innovative    electrons    stimulation    treatments    antiviral    unpleasant    turnover    ionized    reg    pharmacological    price    safe    microorganisms    organic    medical    uv    country    ultrasound    chronic    18    overconsumption    physiological    species    suppliers    costumers    electromagnetic    revolutionize    equals    uses    plasma    900    presenting    electrical    return    bacteria    forming    accelerates    animal    opportunity    generate    constitutes    stimulates    commercialization    manoeuvrable    microorganism    inflammatory    excited    neoplas    feeling    farming    healing    regional    network    area    fungi    gas    antimicrobial    effect    sustainable    ca    cold    obtaining    device    wellbeing    revenues    50    wound    kinpen    efficient    resistant    antibiotics    laser    portable    million    reachable    market    950    first    led    600    animals    calculated    anti    pet    advantages    110    antifungal    surface    veterinary    rising    share    segments   

Project "kINPen" data sheet

The following table provides information about the project.

Coordinator
NEOPLAS GMBH 

Organization address
address: WALTHER RATHENAU STRASSE 49A
city: GREIFSWALD
postcode: 17489
website: www.neoplas.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://www.neoplas.eu/en/veterinarymedicine.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NEOPLAS GMBH DE (GREIFSWALD) coordinator 50˙000.00

Map

 Project objective

The veterinary sector urgently needs to revolutionize their treatment methods in order to solve the present antibiotic overconsumption and related growing resistance. This constitutes an important market opportunity for new technologies. Current non-pharmacological infection treatments such as ultrasound, electrical stimulation, laser or LED, are less efficient, given their cost, unpleasant feeling, treatment-time or required area. Therefore, neoplas GmbH successfully developed kINPen®VET, a non-pharmacological, high-innovative and portable cold plasma device for efficient healing of chronic wounds in farm and pet animals. It stimulates and accelerates physiological wound healing and is highly effective against typical wound bacteria, multidrug-resistant microorganisms and fungi, obtaining antiviral, antimicrobial, antifungal and anti-inflammatory effects on the treated surface without the need of antibiotics or developing microorganism resistance. It is based on cold plasma and uses the advantages of the Plasma Effect (ionized gas, electrons and ions, as well as radicals, excited species, UV radiation and electromagnetic fields). KINPen®VET will provide a 100% safe and manoeuvrable device, leading to a more cost-effective and sustainable veterinary medical treatment. kINPen®VET’s commercialization will generate high revenues in the targeted market segments of animal health and wellbeing and organic animal farming (market share 50%). This equals to an approximate number of more than 110.000 systems presenting a turnover of €950 million only in Europe. This ambitious target is reachable by forming a European network of regional suppliers, representatives and costumers in each targeted country. The production costs have been calculated with 5.900 €/ unit in the first 3 years and with a rising production the costs will be reduced to ca. 4.600 €/unit. The sales price is targeted with 8.900 €/unit and will allow a calculated return on investment in under 18 months.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "KINPEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "KINPEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Presque (2019)

Smart Nursing Bra

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More  

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More